Morgellons Websites

MORGELLONS FROM NIH GOV
http://www.ncbi.nlm.nih.gov/pubmed
 
Exploring the association between Morgellons disease and Lyme disease: identification of Borrelia burgdorferi in Morgellons disease patients.
Middelveen MJ, Bandoski C, Burke J, Sapi E, Filush KR, Wang Y, Franco A, Mayne PJ, Stricker RB.
 
Morgellons Disease Presenting As an Eyelid Lesion.
Sandhu RK, Steele EA.
Ophthal Plast Reconstr Surg. 2014 Sep 4.
 
Information, consent and treatment of patients with Morgellons disease: an ethical perspective.
Söderfeldt Y, Groß D.
Am J Clin Dermatol. 2014 Apr;15(2):71-6. doi: 10.1007/s40257-014-0071-y.
PMID: 24671866, Select item 233283634.[Morgellons syndrome: a disease transmitted via the media].
 
Misery L.
Ann Dermatol Venereol. 2013 Jan;140(1):59-62. doi: 10.1016/j.annder.2012.09.016. Epub 2012 Dec 20. French.
 
Characterization and evolution of dermal filaments from patients with Morgellons disease.
Middelveen MJ, Mayne PJ, Kahn DG, Stricker RB.
Clin Cosmet Investig Dermatol. 2013;6:1-21. doi: 10.2147/CCID.S39017. Epub 2013 Jan 8.
 
Association of spirochetal infection with Morgellons disease.
Middelveen MJ, Burugu D, Poruri A, Burke J, Mayne PJ, Sapi E, Kahn DG, Stricker RB.
F1000Res. 2013 Jan 28;2:25. doi: 10.12688/f1000research.2-25.v1. eCollection 2013.
PMID: 24715950,Select item 229590627.
 
Morgellons disease: more questions than answers.
Stricker RB, Middelveen MJ.
Psychosomatics. 2012 Sep-Oct;53(5):504-5; author reply 505-6. doi: 10.1016/j.psym.2012.05.003. No abstract available.
 
Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease.
Middelveen MJ, Stricker RB.
Clin Cosmet Investig Dermatol. 2011;4:167-77. doi: 10.2147/CCID.S26183. Epub 2011 Nov 14.
 
An oral ulceration associated with Morgellons disease: a case report.
Grosskopf C, Desai B, Stoopler ET.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2011 Aug;112(2):e19-23. doi: 10.1016/j.tripleo.2011.03.045.
 
Psychosis, ivermectin toxicity, and "Morgellons disease".
DeBonis K, Pierre JM.
Psychosomatics. 2011 May-Jun;52(3):295-6. doi: 10.1016/j.psym.2011.01.006. No abstract available.
 
Hypnosis in the treatment of Morgellons disease: a case study.
Gartner AM, Dolan SL, Stanford MS, Elkins GR.
Int J Clin Exp Hypn. 2011 Apr;59(2):242-9. doi: 10.1080/00207144.2011.546263.
 
Morgellons disease and delusions of parasitosis.
Robles DT, Olson JM, Combs H, Romm S, Kirby P.
Am J Clin Dermatol. 2011 Feb 1;12(1):1-6. doi: 10.2165/11533150-000000000-00000.
 
Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet.
Freudenreich O, Kontos N, Tranulis C, Cather C.
Psychosomatics. 2010 Nov-Dec;51(6):453-7. doi: 10.1176/appi.psy.51.6.453. No abstract available.
 
Successful treatment of Morgellons disease with pimozide therapy.
Reid EE, Lio PA.
Arch Dermatol. 2010 Oct;146(10):1191-3. doi: 10.1001/archdermatol.2010.276. No abstract available.
 
Intraoral Morgellons disease or delusional parasitosis: a first case report.
Dovigi AJ.
Am J Dermatopathol. 2010 Aug;32(6):603-5. doi: 10.1097/DAD.0b013e3181ca4a13.
 
Morgellons: contested illness, diagnostic compromise and medicalisation.
Fair B.
Sociol Health Illn. 2010 May;32(4):597-612. doi: 10.1111/j.1467-9566.2009.01227.x. Epub 2010 Feb 12.
 
Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology.
Savely VR, Stricker RB.
Clin Cosmet Investig Dermatol. 2010 May 13;3:67-78.
 
[Do they understand Morgellons disease?].
Wildner M.
Gesundheitswesen. 2009 Dec;71(12):795-6. doi: 10.1055/s-0029-1242727. Epub 2009 Dec 28. German. No abstract available.
 
Morgellons in dermatology.
Harth W, Hermes B, Freudenmann RW.
J Dtsch Dermatol Ges. 2010 Apr;8(4):234-42. doi: 10.1111/j.1610-0387.2009.07219.x. Epub 2009 Oct 29. Review. English, German.
 
Morgellons disease, illuminating an undefined illness: a case series.
Harvey WT, Bransfield RC, Mercer DE, Wright AJ, Ricchi RM, Leitao MM.
J Med Case Rep. 2009 Jul 1;3:8243. doi: 10.4076/1752-1947-3-8243.
 
Disorder or delusion? Living with Morgellons disease.
Simpson L, Baier M.
J Psychosoc Nurs Ment Health Serv. 2009 Aug;47(8):36-41. doi: 10.3928/02793695-20090706-03. Review.
 
Morgellons disease as internet meme.
Lustig A, Mackay S, Strauss J.
Psychosomatics. 2009 Jan-Feb;50(1):90. doi: 10.1176/appi.psy.50.1.90. No abstract available.
 
Morgellons disease and the 'tweezer sign'.
Robles DT.
Clin Exp Dermatol. 2008 Nov;33(6):793-4. doi: 10.1111/j.1365-2230.2008.02739.x. No abstract available.
 
Molyneux J.
Am J Nurs. 2008 May;108(5):25-6. doi: 10.1097/01.NAJ.0000317988.01798.2f. No abstract available.
 
Morgellons disease?
Accordino RE, Engler D, Ginsburg IH, Koo J.
Dermatol Ther. 2008 Jan-Feb;21(1):8-12. doi: 10.1111/j.1529-8019.2008.00164.x.
 
Morgellons: disease or delusions?
Paquette M.
Perspect Psychiatr Care. 2007 Apr;43(2):67-8. No abstract available.
 
Morgellons disease.
Harvey WT.
J Am Acad Dermatol. 2007 Apr;56(4):705-6. No abstract available.
 
The challenge of Morgellons disease.
Koblenzer CS.
J Am Acad Dermatol. 2006 Nov;55(5):920-2. Review. No abstract available.
 
Morgellons disease?
Waddell AG, Burke WA.
J Am Acad Dermatol. 2006 Nov;55(5):914-5. No abstract available.
 
Morgellons disease: a rapport-enhancing term for delusions of parasitosis.
Murase JE, Wu JJ, Koo J.
J Am Acad Dermatol. 2006 Nov;55(5):913-4. No abstract available.
 
Pimozide at least as safe and perhaps more effective than olanzapine for treatment of Morgellons disease.
Koblenzer CS.
Arch Dermatol. 2006 Oct;142(10):1364. No abstract available.
 
Mysterious 'Morgellons disease' prompts US investigation.
Marris E.
Nat Med. 2006 Sep;12(9):982. Epub 2006 Aug 30. No abstract available.
 
The mystery of Morgellons disease: infection or delusion?
Savely VR, Leitao MM, Stricker RB.
Am J Clin Dermatol. 2006;7(1):1-5. Review.
 
Myiasis, fillan, and the morgellons.
EMSLIE-SMITH AH.
Br Med J. 1946 Jun 22;1:962. No abstract available.

J Med Case Rep. 2009 Jul 1;3:8243. doi: 10.4076/1752-1947-3-8243.
Morgellons disease, illuminating an undefined illness: a case series.
Harvey WT, Bransfield RC, Mercer DE, Wright AJ, Ricchi RM, Leitao MM.
Abstract
INTRODUCTION:
This review of 25 consecutive patients with Morgellons disease (MD) was undertaken for two primary and extremely fundamental reasons. For semantic accuracy, there is only one "proven" MD patient: the child first given that label. The remainder of inclusive individuals adopted the label based on related descriptions from 1544 through 1884, an internet description quoted from Sir Thomas Browne (1674), or was given the label by practitioners using similar sources. Until now, there has been no formal characterization of MD from detailed examination of all body systems. Our second purpose was to differentiate MD from Delusions of Parasitosis (DP), another "informal" label that fit most of our MD patients. How we defined and how we treated these patients depended literally on factual data that would determine outcome. How they were labeled in one sense was irrelevant, except for the confusing conflict rampant in the medical community, possibly significantly skewing treatment outcomes.
CASE PRESENTATION:
Clinical information was collected from 25 of 30 consecutive self-defined patients with Morgellons disease consisting of laboratory data, medical history and physical examination findings. Abnormalities were quantified and grouped by system, then compared and summarized, but the numbers were too small for more complex mathematical analysis. The quantification of physical and laboratory abnormalities allowed at least the creation of a practical clinical boundary, separating probable Morgellons from non-Morgellons patients. All the 25 patients studied meet the most commonly used DP definitions.
CONCLUSIONS:
These data suggest Morgellons disease can be characterized as a physical human illness with an often-related delusional component in adults. All medical histories support that behavioral aberrancies onset only after physical symptoms. The identified abnormalities include both immune deficiency and chronic inflammatory markers that correlate strongly with immune cytokine excess. The review of 251 current NLM DP references leads us to the possibility that Morgellons disease and DP are grossly truncated labels of the same illness but with the reversal of the cause-effect order. Further, the patients' data suggest that both illnesses have an infectious origin.